tirzepatide march 19th Beware of Compounded Tirzepatide | 2023788-19-2
Description
Patients should report concerning symptoms promptly, including persistent gastrointestinal symptoms, signs of gallbladder disease (right upper quadrant pain), or signs of pancreatitis
The authors and the publisher do not endorse or recommend any specific tests, physicians, products, procedures, opinions, or other information that may be mentioned in the article
Added ingredients: Some compounded products may contain additional ingredients
Medicare is largely prohibited from paying for weight-loss drugs, though there have been efforts by drugmakers and advocates for Congress to change that
